FitLife Brands, Inc. (FTLF) - Q3 2024 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended September 30, 2024. FitLife Brands, Inc. is a provider of nutritional supplements and wellness products operating under four primary brand collections: Legacy FitLife (NDS Nutrition, iSatori, etc.), MRC (Dr. Tobias, Maritime Naturals), and the recently acquired MusclePharm. The company distributes products through wholesale partners (notably GNC) and direct-to-consumer online channels.
Key Financial Metrics
| Metric | Q3 2024 (3 Months) | Q3 2023 (3 Months) | YTD 2024 (9 Months) | YTD 2023 (9 Months) |
|---|---|---|---|---|
| Revenue | $15,977 | $13,902 | $49,456 | $39,401 |
| Gross Profit | $7,001 | $5,696 | $21,868 | $16,069 |
| Gross Margin | 43.8% | 41.0% | 44.2% | 40.8% |
| Operating Income | $3,182 | $2,470 | $10,238 | $5,728 |
| Net Income | $2,126 | $1,696 | $6,914 | $3,816 |
| Diluted EPS | $0.43 | $0.35 | $1.40 | $0.78 |
| Cash & Equivalents | $4,664 (as of Sept 30, 2024) | |||
| Total Debt (Term Loans) | $14,164 (Net of deferred costs) | |||
| Working Capital | $6,044 (as of Sept 30, 2024) |
Note: All financial figures are in thousands, except per share data.
Material Changes vs. Prior Period
- Revenue Growth: Q3 2024 revenue increased 15% year-over-year, driven primarily by the inclusion of MusclePharm (acquired Oct 2023) and growth in MRC, partially offset by a 6% decline in Legacy FitLife revenue.
- Margin Expansion: Gross margin improved to 43.8% in Q3 2024 from 41.0% in Q3 2023. This was due to higher margins in MRC and Legacy FitLife, as well as the optimization of unprofitable international markets for MRC's skincare brands.
- Expense Management: Advertising and marketing expenses decreased 14% in Q3 2024 due to rationalization of spend. However, SG&A increased 39% due to higher personnel costs, professional fees, and $184 in non-recurring severance costs.
- Debt Reduction: The company made a voluntary prepayment of $2.5 million on Term Loan A in Q1 2024. Total term loan principal outstanding decreased from $20,125 at year-end 2023 to $14,250 at Q3 2024.
- Cash Flow: Net cash provided by operating activities for the nine months ended Sept 30, 2024, was $8,653, a significant increase from $2,772 in the prior year period.
Guidance, Outlook, and Risks
- Outlook: Management anticipates that cash flow from operations and existing cash reserves, along with available borrowings under the $3.5 million Line of Credit (maturing Dec 2024), will be sufficient for liquidity needs over the next 12 months. No specific numerical guidance for future quarters was provided in this filing.
- Acquisition Integration: The company is actively integrating MusclePharm, with revenue split roughly 50/50 between wholesale and online channels. Management is making targeted investments in advertising to drive growth for this brand.
- Key Risks:
- Customer Concentration: GNC represents 23% of Q3 2024 revenue and 28% of accounts receivable. Declining customer counts in brick-and-mortar wholesale stores remain a challenge for Legacy FitLife.
- Debt Covenants: The company must maintain a Fixed Charge Coverage Ratio of at least 1.25 and a Funded Debt to EBITDA Ratio of no more than 2.50. The company was in compliance as of September 30, 2024.
- Goodwill Impairment: The company holds significant goodwill ($13.1 million) and intangible assets ($26.3 million). Fair value is sensitive to stock price fluctuations; no impairment indicators were noted as of Q3 2024.
Investor Verification Checklist
- Verify the sustainability of the 43.8% gross margin given the decline in wholesale revenue for Legacy FitLife.
- Monitor the performance of the MusclePharm brand in Q4 2024 to confirm if the sequential revenue decline observed in Q3 was purely seasonal.
- Review the status of the $3.5 million Line of Credit maturing in December 2024 and any plans for renewal or refinancing.
- Assess the impact of the $184 severance cost on future SG&A trends and whether this was a one-time event.
- Confirm continued compliance with debt covenants, specifically the Fixed Charge Coverage Ratio, in light of interest rate fluctuations (SOFR + 2.75%).